Ophthalmic insights

The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children...

The Centre for Eye Health (CFEH)’s inaugural director Professor Michael Kalloniatis has left the organisation amid a strategic review that...

In my roles as an employer of optometrists and an academic, it seemed to me mental health issues and burnout...

About 5000 people are expected to participate in Australia’s first national survey combining ear and eye health, launched on 3...

The Therapeutic Goods Administration (TGA) has granted Lucentis (ranibizumab) an indication for retinopathy of prematurity (ROP), making it the first...

Dropout, hygiene compliance and other issues associated with contact lens wear will be the focus of a new study by...

Data from patients with a subtype of AMD enrolled in Opthea’s Phase 2b clinical trial of OPT-302 in combination with...

A new paper by Australian and US investigators examining glaucoma suspects has found more frequent six-monthly reviews actually cost the...

An international research group has discovered a significant increase in tear secretion and tear film stability after participating in aerobic...

After 10 extremely rewarding years leading the ProVision organisation, it is time for me to leave the wonderful industry of...